Contact dermatitis from pyrrolnitrin.
D000287:Administration, Topical; D000935:Antifungal Agents / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000209:etiology*; D003881:Dermatomycoses / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D011764:Pyrrolnitrin / Q000009:adverse effects*
D000935:Antifungal Agents; D011764:Pyrrolnitrin